Increasing neutrophil-to-lymphocyte ratio following radiation is a poor prognostic factor and directly correlates with splenic radiation dose in pancreatic cancer-Reference-Cited by-同舟云学术

Increasing neutrophil-to-lymphocyte ratio following radiation is a poor prognostic factor and directly correlates with splenic radiation dose in pancreatic cancer

Published:2021-05 Issue: Volume:158 Page:207-214
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Wolfe Adam R.^ORCID,Siedow Michael^ORCID,Nalin Ansel^ORCID,DiCostanzo Dominic^ORCID,Miller Eric D.^ORCID,Diaz Dayssy Alexandra,Arnett Andrea,Cloyd Jordan M.^ORCID,Dillhoff Mary,Ejaz Aslam,Tsung Allan,Williams Terence M.^ORCID

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference32 articles.

1. Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience;Cloyd;J Gastrointest Surg.,2017

2. Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil;Moertel;The gastrointestinal tumor study group. Cancer.,1981

3. Treatment of Locally Unresectable Carcinoma of the Pancreas: Comparison of Combined-Modality Therapy (Chemotheraphy Plus Radiotherapy) to Chemotheraphy Alone1

4. Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an eastern cooperative Oncology Group Trial;Loehrer;J Clin Oncol,2011

5. Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib: The lap07 randomized clinical trial;Hammel;JAMA,2016

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic value of sarcopenia and inflammatory indices synergy in patients with esophageal squamous cell carcinoma undergoing chemoradiotherapy;BMC Cancer;2024-07-18

2. Nab-paclitaxel plus S-1 versus nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer: a multicenter, randomized, phase II study;The Oncologist;2024-07-11

3. Translational Frontiers and Clinical Opportunities of Immunologically Fitted Radiotherapy;Clinical Cancer Research;2024-03-13

4. Predictive indicators of immune therapy efficacy in hepatocellular carcinoma based on neutrophil-to-lymphocyte ratio;International Immunopharmacology;2024-02

5. Radiation-Induced Innate Neutrophil Response in Tumor Is Mediated by the CXCLs/CXCR2 Axis;Cancers;2023-12-01